Equities
Silexion Therapeutics raises $2.5M in $0.65 share public offering
Biotech firm Silexion Therapeutics priced a public offering of 3.85 million shares at $0.65 each, raising $2.5 million to fund pipeline development.
Dexus Industria FY26 outlook lifts FFO above forecast
FFO for Dexus Industria exceeds guidance while portfolio yields reach 7% in full-year 2026 outlook.
Dexus Industria FY26 slides show FFO beat on pure-play shift
FY2026 outlook slides indicate funds from operations exceeded forecasts as Dexus Industria accelerates its transition to a pure-play logistics property group.
Apax-backed fund prices $8 million OPENLANE share offering
The offering follows a private placement of 8 million shares at $1 each, valuing the company at $8 million. Apax Partners holds a majority stake.
Laekna’s breast cancer drug application accepted in China
Chinese regulator accepts Laekna’s application for a novel breast cancer therapy, marking a key step toward commercialization in the country’s growing oncology market.
ARK sells Deere, buys Rocket Lab in latest portfolio shift
Cathie Wood's ARK Investment Management trimmed exposure to Deere & Co. while adding shares of space company Rocket Lab in its latest 13F filing.
U.S. Rep. Gottheimer reports Alphabet trades amid congressional scrutiny
New Jersey Democrat Josh Gottheimer disclosed multiple stock transactions in Alphabet, Meta and other companies, per federal filings. The trades come as lawmakers face heightened scrutiny over potential conflicts of interest.
U.S. Rep. Kevin Hern reports major stock, Treasury trades
Oklahoma Republican discloses significant transactions in equities and government securities, as required by federal ethics rules.
U.S. Congressman discloses trades in Applied Materials, BlackRock, Palo Alto Networks
Rep. John McGuire III reported purchases of shares in three major firms, including a BlackRock ETF, following recent market activity.
U.S. Antimony misses earnings by $0.03, revenue below estimates
Antimony producer reported a per-share loss of $0.04 versus a $0.01 profit forecast, with revenue declining 12% year-over-year.
Gladstone Land Q2 earnings miss estimates by $0.05 per share
Revenue exceeded expectations as the farmland REIT reported Q2 results, though adjusted FFO fell short of analyst forecasts.
Suncorp underlying earnings rise 5% on premium growth
Australian insurer posts higher underwriting profits amid strong demand for home and car insurance, lifting shares.
Nvidia reduces $250 billion OpenAI data center commitment: WSJ
Chipmaker scales back financial backing for OpenAI's data center expansion amid rising capital costs and strategic reassessment.
CoreWeave Q2 2026 revenue doubles, backlog jumps 246%
AI infrastructure provider posts sharp growth in quarterly revenue and project backlog, signaling strong demand for high-performance computing capacity.
Supermicro forecasts $72B revenue in FY27 after Q4 sales surge
Server maker Supermicro reports FY26 Q4 revenue more than doubled year-over-year, with management outlining a $72 billion target for FY27. Shares rise on outlook.
Vinci Compass Q2 2026: FRE up 36% on acquisitions, scale gains
Freight revenue equivalent surged after strategic buyouts and operational expansion, according to internal slides reviewed by Reuters.
NeuroPace sees 21% RNS growth, $55B+ market opportunity by 2026
Medical device maker NeuroPace projects a 21% compound annual growth rate for its responsive neurostimulation system through 2026, citing a $55 billion-plus addressable market.
Grupo Supervielle forecasts Q2 2026 profit, 20% net interest margin
Argentine lender sees return to profitability in mid-2026 as net interest margin climbs to 20%, according to presentation slides.
ESS Tech pivots to sodium-ion batteries as revenue collapses 97%
Second-quarter 2026 results show near-total revenue decline, prompting shift from zinc-based to sodium-ion technology amid cost pressures.
CI&T posts strong Q2 2026 revenue growth, invests in margins
Brazilian IT services firm CI&T reported strong revenue growth in Q2 2026, with a strategic focus on margin expansion amid ongoing investment cycle.
Velo3D Q2 2026 revenue rises 52%, raises guidance
3D printing firm Velo3D reports strong Q2 2026 revenue growth and upgrades full-year outlook after exceeding expectations.
NCM Q2 2026 revenue rises 13% on Captivate deal
National CineMedia reports a 13% year-over-year revenue increase in Q2 2026, driven by its acquisition of Captivate Network.
Blue Owl raises $750 million via senior notes at 6.75% yield
The asset manager priced a $750 million senior notes offering at a 6.75% yield, reflecting elevated borrowing costs amid tight credit conditions.
Lumentum posts record Q4 FY26 margins as AI demand surges
Optical components supplier Lumentum reports gross margins exceeding 50% in Q4 FY26, citing AI-driven demand as the key driver behind its record profitability.